Drug Database
PR

prednisolone

✓ Approved

Takeda · NR3C1 · 小分子

什么是 prednisolone?

prednisolone 是一种小分子,由Takeda研发。该药已获批,用于治疗相关适应症,给药途径:Oral (PO)。

药物档案

公司Takeda
药物类别小分子
分子靶点NR3C1
给药途径Oral (PO)
状态Approved

作用机制

分子靶点

prednisolone 作用于 1 个分子靶点:

NR3C1nuclear receptor subfamily 3 group C member 1 (GR, GCCR)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

prednisolone 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Neoplasms benign, malignant and unspecified (incl cysts and polyps)Plasma cell myeloma✓ Approved

相关研究文献

PubMedBMC neurology2026-11-19

Inflammatory diseases of the central nervous system in adults at the Brazzaville University Hospital Center, Congo.

Diatewa J E JE, Sounga-Bandzouzi E P EP, Motoula-Latou D A Boubayi DAB, Mpandzou G A GA et al.

Inflammatory diseases (IDs) of the central nervous system (CNS) constitute a heterogeneous group of immune-mediated disorders that can lead to neurological disability. Data on these diseases remain limited in sub-Saharan Africa. To describe the epidemiological, clinical, and paraclinical aspects of CNS IDs in adults in Brazzaville, Congo; to describe the therapeutic strategies implemented; to evaluate the outcome of pathological entities at hospital discharge. This was a retrospective descriptive study carried out in the neurology department of the Brazzaville University Hospital Center. The study period was from January 2018 to December 2023. The study included patients aged 18 years or older. The diagnosis of each entity of CNS IDs was based on clinical data, MRI findings, cerebrospinal fluid analysis, and available laboratory investigations, according to international consensus criteria for this disease. At hospital discharge, the documented clinical outcome was as follows: improvement, stabilization, or deterioration. Of the 44 patients included in the study, 29 (65.9%) were women. The average age of the patients was 35.0 ± 9.9 years. The most common diagnostic categories were idiopathic acute transverse myelitis (n = 10), unclassified acute inflammatory medullary syndrome (n = 10), neuromyelitis optica spectrum disorders (n = 5), and isolated optic neuritis (n = 5). Intravenous corticosteroid therapy with methylprednisolone was administered to all patients, followed by oral prednisolone. Maintenance immunosuppressive therapy was initiated in 5 (11.4%) patients. At hospital discharge, three types of outcomes for CNS IDs were recorded: clinical improvement (n = 29; 65.9%); stabilization (n = 10; 22.7%), and deterioration (n = 5; 11.4%). The spectrum of CNS IDs in adults in Brazzaville is broad. In our cohort, IDs of the CNS are predominantly characterized by spinal cord syndromes. The lack of specific biomarkers has limited the accuracy of the diagnosis. Overall, the immunosuppressive therapy used has led to a clinical improvement in most patients at hospital discharge.

PMID 43052790
阅读全文 →
PubMedDermatitis : contact, atopic, occupational, drug2026-11-18

Periorbital Allergic Contact Dermatitis to Sodium Metabisulfite in Prednisolone Acetate Ophthalmic Suspension.

Thiraviyarajah Vaish V, Khouri Ashley A, Schlarbaum Jamie P JP

PMID 43046635
阅读全文 →
PubMedEJHaem2026-11-18

How We Use Corticosteroids in Immune Thrombocytopenia.

Gurumurthy Gerard G, Morgan Mervyn M, Provan Drew D, Thachil Jecko J

Corticosteroids remain an important first-line treatment for immune thrombocytopenia (ITP), but their benefits are accompanied by substantial toxicities across various body systems. Their use should therefore be individualised and time-limited. We synthesise current guidance and published evidence concerning the selection of patients for corticosteroids treatment, choice of regimen, prevention and monitoring of treatment-related toxicity, recognition of response and non-response, and structured tapering and discontinuation in adults with ITP. Corticosteroids should be avoided when observation is clinically appropriate and, when prescribed, should have a pre-defined indication, haemostatic control target, expected time to response and stopping date. Accepted first-line regimens include prednisolone at 1-2 mg/kg/day, generally capped at 60-80 mg daily, or high-dose dexamethasone at 40 mg daily for 4 days. A platelet count exceeding 50  ×  109/L within 5-7 days generally identifies an early responder, although a lower count may be adequate when bleeding has resolved and haemostatic safety has been achieved. Responders receiving prednisolone should proceed to dose reduction and complete discontinuation within approximately 6-8 weeks. Patients without an adequate early response should have prednisolone tapered over approximately 2 weeks and with prompt consideration of an alternative or steroid-sparing treatment rather than prolonged dose escalation. Treatment extending beyond 3 weeks, particularly at doses exceeding 5 mg/day of prednisolone equivalent, may confer a risk of hypothalamic-pituitary-adrenal axis suppression and require a more structured taper. Clinicians must balance the therapeutic goals of corticosteroids against the risk of toxicities from their use. The objective of corticosteroid therapy in ITP is to achieve haemostatic safety rather than to elevate or normalise the platelet count. The authors have confirmed clinical trial registration is not needed for this submission.

PMID 43048703
阅读全文 →
PubMedCureus2026-11-18

Early Neonatal Presentation and Management of Diamond-Blackfan Anemia: A Case Report.

de Liz Arcari Henrique H

Diamond-Blackfan anemia (DBA) is a rare congenital red cell aplasia that may present with severe anemia in early infancy. This report describes a case with very early neonatal presentation and a favorable hematologic response to corticosteroid therapy. A term male infant was presented at two days of life with marked pallor, feeding refusal, and severe anemia, with a hemoglobin level of 6.7 g/dL, requiring a red blood cell transfusion. After recurrent episodes of severe anemia, further investigation demonstrated macrocytosis, reticulocytopenia, and a normocellular bone marrow with rare erythroblasts, supporting the diagnosis of DBA. Oral prednisolone was initiated at one month 15 days of age and was associated with subsequent hematologic improvement, allowing gradual dose reduction. At the latest follow-up, the patient was 17 months old and had remained transfusion-independent for 14 months while receiving maintenance prednisolone. This case highlights the importance of considering DBA in neonates with unexplained severe anemia and reticulocytopenia, even in the absence of congenital anomalies. The hematologic response and sustained transfusion independence demonstrate a favorable clinical course following individualized management, with continued follow-up needed to assess long-term response and treatment safety.

PMID 43048496
阅读全文 →
PubMedInternal medicine (Tokyo, Japan)2026-11-18

Hypersensitivity Pneumonitis with the Progression of Latent Autoimmune Pulmonary Alveolar Proteinosis after Steroid Treatment.

Arai Toru T, Hirose Masaki M, Takimoto Takayuki T, Takeuchi Naoko N et al.

A 57-year-old female patient was referred to our hospital. Bronchoalveolar lavage (BAL) fluid showed lymphocytosis with a CD4/CD8 ratio of 11.1 and a few periodic acid-Schiff (PAS)-positive large-sized proteinaceous materials, suggesting pulmonary alveolar proteinosis (PAP). A lung biopsy suggested fibrotic hypersensitivity pneumonitis (FHP) with mild PAP. The patient was diagnosed with FHP with autoimmune PAP and tested positive for anti-granulocyte-macrophage colony-stimulating factor antibody (GMAb). BAL performed 3 years after the initiation of prednisolone showed increased PAS-positive material with GMAb levels below the cutoff level. Mild PAP and FHP with a positive GMAb had better be managed as a comorbidity of autoimmune PAP.

PMID 43051902
阅读全文 →
PubMedEuropean journal of rheumatology2026-11-18

Focal Digital Clubbing as an Initial Symptom of Adolescent-Onset Systemic Lupus Erythematosus: A Case Report.

Sato Masayuki M, Nagamori Tsunehisa T, Kurisawa MioJune M, Tsuda Junki J et al.

Digital clubbing is typically linked to pulmonary or cardiovascular diseases. There have been no reported cases of systemic lupus erythematosus (SLE) where the initial complaint was solely foca digital clubbing and a chilblain-like rash on the ngers. A 13-year-old girl experienced digital clubbing for 3 months. Physical examination revealed focal digital clubbing of the thumb, index nger, and middle nger on her right hand, along with slight blotchy erythema assessed as a chilblain-like rash. Laboratory data showed hypocomplementemia and a high anti-double-stranded DNA antibody titer. She was also positive for antiphospholipid antibodies, had prolonged prothrombin time and activated partial thromboplastin time, and elevated anti-prothrombin antibody levels. She was diagnosed with SLE complicated by hypoprothrombinemia associated with lupus anticoagulant. Prednisolone treat ment resolved the digital clubbing and laboratory abnormalities. Digital clubbing may be an initial symptom of SLE. Screening for autoimmune diseases should be considered when a patient presents with digital clubbing not associated with pulmonary or cardiovascular diseases or malignant tumors.   Cite this article as: Sato M, Nagamori T, Kurisawa MJ, Tsuda J, Ishibazawa E, Takahashi S. Focal digital clubbing as an initial symptom of adolescent-onset systemic lupus erythematosus: a case report. Eur J Rheumatol. 2025, 12(4), 0075, doi:10.5152/eurjrheum.2025.24075.

PMID 43049123
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多prednisolone